What You Need to Know about COVID-19 and Down Syndrome
Discussion about what you need to know about Covid-19 and Down syndrome with panelists Nicole Baumer, M.D., M.Ed, Stephanie Santoro,
November 5, 2021
Discussion about what you need to know about Covid-19 and Down syndrome with panelists Nicole Baumer, M.D., M.Ed, Stephanie Santoro,
In this video Zachary Rossetti, Ph.D. discusses how to help promote friendship and social connections during the pandemic and beyond.
In this video, Libby Kumin, Ph.D., CCC-SLP discusses language skills for children in the first grade and into middle school.
General Vaccine InformationSource: Advocate Medical Group Adult Down Syndrome Center
Dr. Stephanie Santoro with the Mass General Down Syndrome Program discuss a relatively newly recognized condition called by several names
“It is unknown to what degree aducanumab (Aduhelm) may help people with Down syndrome, as they were not included among
In June of 2021, the FDA approved a new drug, Aduhelm, from the company Biogen for the treatment of mild
Regression is a term for the loss of previously acquired developmental skills in an individual. This can be in the
The NTG brought together a national panel of expert researchers and practitioners in the field of Down syndrome and Alzheimer’s
Today, individuals with Down syndrome enjoy a longer life expectancy and are now able to live into their sixties. Unfortunately,